The cycle of development, publication, and implementation of clinical practice guidelines for CKD

Insights

Clinical practice guidelines (CPGs) improve patient outcomes. For chronic kidney disease (CKD), automatic reporting of estimated glomerular filtration rate (eGFR) with decision support is crucial for guideline implementation.

Area of Science:

  • Nephrology
  • Clinical Practice Guidelines
  • Health Informatics

Background:

  • Clinical practice guidelines (CPGs) are essential for improving patient care and outcomes.
  • The Kidney Disease Outcomes Quality Initiative (KDOQI) developed guidelines for chronic kidney disease (CKD).
  • Early CKD guidelines recommended using estimated glomerular filtration rate (eGFR) over creatinine clearance to assess kidney function.

Purpose of the Study:

  • To evaluate the implementation of the first K/DOQI CKD guideline recommendation.
  • To determine the necessity of automatic eGFR reporting with clinical decision support for guideline adoption.
  • To inform the ongoing development and implementation of future CKD CPGs.

Main Methods:

  • The study analyzed the implementation process of the K/DOQI guideline for CKD.
  • It focused on the role of automatic reporting of eGFR in clinical workflows.
  • Clinical decision support systems integrated with eGFR reporting were examined.

Main Results:

  • Automatic reporting of eGFR, coupled with clinical decision support, was demonstrated to be essential for the successful implementation of the CKD guideline.
  • This approach facilitated the shift from 24-h urine collections to eGFR for kidney function assessment.
  • The findings highlight a key factor for effective CPG dissemination.

Conclusions:

  • The integration of technology, specifically automated eGFR reporting and decision support, is critical for translating clinical guidelines into practice.
  • Successful implementation of CKD guidelines relies on robust health informatics infrastructure.
  • Lessons learned are vital for the current cycle of CKD CPG development and implementation.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...